Home >> Signaling Pathways >> Others >> Menin-MLL


Menin-MLL interaction is a drug target for leukemia treatment. Menin is a multiple endocrine neoplasia (MEN1) products which interacts with MLL (mixed lineage leukemia) in a histone methyltransferase complex.

Products for  Menin-MLL

  1. Cat.No. 产品名称 Information
  2. GC11837 MI-136 A menin-MLL inhibitor
  3. GC11418 MI-2

    Menin-MLL inhibitor 2;Thieno[2,3-d]pyrimidine, 4-[4-(4,5-dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-propyl-

    An inhibitor of menin-MLL fusion protein interactions
  4. GC10388 MI-2 (hydrochloride) An inhibitor of menin-MLL interactions
  5. GC12199 MI-3

    Menin-MLL inhibitor 3;Thieno[2,3-d]pyrimidine, 4-[4-(4,5-dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-(1-methylethyl)-

    An inhibitor of menin-MLL fusion protein interactions
  6. GC12173 MI-nc (hydrochloride) A negative control for MI-2

5 Item(s)

per page

Set Descending Direction